Yeztugo
NDC 61958-3401, LENACAPAVIR SODIUM, tablet, film coated, from Gilead Sciences, Inc..
- Product NDC
- 61958-3401
- Status
- Listed
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LENACAPAVIR SODIUM300 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Capsid Inhibitors [MoA]; Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61958-3401-1 | 61958340101 | 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1c241af1-ce62-4b0a-9eb7-f6b626174f01Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61958-3401
Use it
Look up 61958-3401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61958-3401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.